AI In-Brief

Thailand News in Brief

Thai PBS World

Thailand and the world, every day

AI can make mistakes. Please double-check.

U.S. regulators approve first new Alzheimer’s drug in nearly 20 years

23 Sept 05:38 Key points summarised by AI

U.S. regulators approved Biogen's aducanumab (Aduhelm), the first new Alzheimer's drug in nearly 20 years, despite controversy surrounding its clinical evidence.
Aduhelm works by removing amyloid beta plaques to slow disease progression, not cure it, and is priced at $56,000 annually, causing Biogen's shares to surge.
The FDA granted "accelerated approval" due to the drug's potential benefit, mandating Biogen conduct further confirmatory clinical trials to validate its efficacy.
The approval generates hope for patients but also sparks debate among experts regarding its effectiveness, high cost, and broad patient eligibility, raising concerns about healthcare system expenses.

Yesterday 12:56 Key points summarised by AI

President Macron condemned widespread rioting and looting during nationwide protests, blaming far-left activists and criminals for the "unrestrained violence" and vowing accountability for those who "sought to bring down the Republic."
Over 2,400 arrests were made as protests against rising living costs and poor school conditions escalated, causing extensive damage to public buildings and businesses in cities like Paris, Limoges (where City Hall burned), Marseille, and Lyon.
The unrest, which organizers hoped would revive the "yellow vest" movement, saw political leaders trade blame, with Macron instructing prefects to protect public buildings and potentially ban future protests to prevent further disorder.